Interestingly, in the current cohort, a child with Down Syndrome related AML (ML-DS) who was excluded a-priori from the analysis, harboured the same RUNX1 mutation in remission, suggesting a germline mutation (data not shown). Here, RUNX1 is linked to acute myeloid leukemia.